AstraZeneca
-
Jul 17 2021US FDA’s CRDA committee votes against approval of AstraZeneca’s roxadustat to treat anaemia in chronic kidney disease
AstraZeneca announced that the Food and Drug Administration’s (FDA) Cardiovascular…
Read more
